Ekachai Medical Care PCL (BKK:EKH)
Thailand · Delayed Price · Currency is THB 5.15
+0.15 (3.00%)
Aug 14, 2026, 2:09 PM ICT
Ekachai Medical Care PCL Ratios and Metrics
Market cap in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 4,000 | 3,968 | 5,433 | 5,184 | 5,737 | 4,380 | |
Market Cap Growth | -13.04% | -26.97% | 4.80% | -9.63% | 30.97% | 48.07% |
Enterprise Value | 3,313 | 3,145 | 4,171 | 4,447 | 5,141 | 4,167 |
Last Close Price | 5.00 | 4.67 | 5.72 | 5.92 | 6.46 | 5.25 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 15.61 | 15.13 | 19.40 | 17.44 | 10.41 | 12.70 |
Forward PE | 16.15 | 17.06 | 17.38 | 19.87 | 24.29 | 20.11 |
PS Ratio | 3.21 | 3.20 | 4.16 | 4.29 | 5.47 | 3.82 |
PB Ratio | 1.51 | 1.56 | 1.92 | 2.44 | 2.97 | 3.97 |
P/TBV Ratio | 1.65 | 1.68 | 2.04 | 2.47 | 3.01 | 4.06 |
P/FCF Ratio | - | - | 86.78 | 18.46 | 24.38 | 15.14 |
P/OCF Ratio | 10.90 | 12.53 | 17.51 | 14.28 | 17.48 | 11.78 |
PEG Ratio | - | 3.03 | 3.03 | 3.03 | 3.04 | 0.54 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.66 | 2.54 | 3.19 | 3.68 | 4.90 | 3.64 |
EV/EBITDA Ratio | 8.77 | 8.47 | 10.80 | 11.29 | 16.48 | 9.50 |
EV/EBIT Ratio | 11.20 | 10.59 | 13.59 | 14.10 | 21.23 | 11.25 |
EV/FCF Ratio | - | - | 66.62 | 15.84 | 21.85 | 14.40 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.02 | 0.03 | 0.03 | 0.01 | 0.01 | 0.03 |
Debt / EBITDA Ratio | 0.17 | 0.20 | 0.19 | 0.04 | 0.07 | 0.07 |
Debt / FCF Ratio | - | - | 1.23 | 0.06 | 0.10 | 0.10 |
Net Debt / Equity Ratio | -0.34 | -0.38 | -0.60 | -0.47 | -0.40 | -0.22 |
Net Debt / EBITDA Ratio | -2.44 | -2.59 | -4.40 | -2.52 | -2.47 | -0.55 |
Net Debt / FCF Ratio | 4.70 | 13.08 | -27.14 | -3.54 | -3.28 | -0.84 |
Asset Turnover | 0.41 | 0.41 | 0.47 | 0.51 | 0.59 | 0.98 |
Inventory Turnover | 18.84 | 18.90 | 20.64 | 20.52 | 18.94 | 20.25 |
Quick Ratio | 4.22 | 3.83 | 7.98 | 5.32 | 4.46 | 2.14 |
Current Ratio | 4.42 | 4.00 | 8.16 | 5.50 | 4.63 | 2.44 |
Return on Equity (ROE) | 10.26% | 10.10% | 11.70% | 14.88% | 36.29% | 34.73% |
Return on Assets (ROA) | 6.15% | 6.08% | 6.83% | 8.38% | 8.45% | 19.84% |
Return on Invested Capital (ROIC) | 14.52% | 17.60% | 22.19% | 22.28% | 19.24% | 37.45% |
Return on Capital Employed (ROCE) | 10.80% | 11.20% | 10.50% | 14.00% | 11.80% | 32.30% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 6.45% | 6.61% | 5.16% | 5.73% | 9.61% | 7.87% |
FCF Yield | -4.80% | -1.86% | 1.15% | 5.42% | 4.10% | 6.61% |
Dividend Yield | 6.00% | 6.42% | 9.61% | 4.94% | 4.71% | 4.36% |
Payout Ratio | 86.29% | 84.85% | 153.61% | 72.65% | 14.15% | 39.87% |
Buyback Yield / Dilution | -1.08% | -6.39% | -2.04% | -5.83% | -8.22% | -0.40% |
Total Shareholder Return | 4.92% | 0.04% | 7.58% | -0.89% | -3.51% | 3.96% |